3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
37
Lymphoma, Follicular
14
Lymphoma, Large B-Cell, Diffuse
12
Lymphoma
8
Lymphoma, Non-Hodgkin
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Lymphoma, B-Cell, Marginal Zone
4
Recurrence
3
Neoplasms
3
Lymphoma, Mantle-Cell
3
Smoldering Multiple Myeloma
2
Myelodysplastic Syndromes
2
Leukemia, Plasma Cell
2
Leukemia, Myelomonocytic, Chronic
2
Burkitt Lymphoma
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Plasma Cell
1
Lymphoma, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Diseases
1
HTLV-I Infections
1
GATA2 Deficiency
1
Anemia, Refractory, with Excess of Blasts
1
Anemia
1
Interventions
Cyclophosphamide
4
fludarabine
3
acalabrutinib
3
pirtobrutinib
2
obinutuzumab
2
Rituximab
2
ricolinostat
1
idelalisib
1
ibrutinib
1
fludarabine phosphate
1
Vincristine
1
Prednisone
1
Mesna
1
Leukapheresis
1
Doxorubicin
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, B-Cell
×
Lenalidomide
×
30 days
×
Clear all
No trials found.